Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorFirst Affiliated Hospital Xi'an Jiaotong University

About this trial

Large Artery Atherosclerosis is one of the most prevalent causes of stroke worldwide and is associated with a high risk of disability and recurrent strokes. Remote Ischemic Conditioning (RIC) is a promising therapy, and it has been recommended for further investigation in patients with acute ischemic stroke resulting from large artery atherosclerosis. The primary objective of this study is to assess the efficacy of RIC in patients suffering from acute moderate ischemic stroke due to large artery atherosclerosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female with age from 18 to 85 years old;

Randomization must be within 48 hours after stroke symptom onset;

Ischemic stroke confirmed by MRI diffusion-weighted imaging;

NIHSS score 6-16, or 4-5 with disabling deficits at the time of randomization. The following typically should be considered disabling deficits: Complete hemianopsia (≥2 on NIHSS question 3) or severe aphasia (≥2 on NIHSS question 9), or visual or sensory extinction (≥1 on NIHSS question 11) or any weakness limiting sustained effort against gravity (≥2 on NIHSS question 6 or 7);

Disqualifiers

Thrombolysis or endovascular therapy performed or planned for index event;

Suspected or confirmed cardioembolic source of stroke: i. The aetiology of cardiogenic embolism with high embolic potential, such as atrial fibrillation, atrial flutter, rheumatic mitral or aortic stenosis, artificial heart valve, left atrial myxoma, valve neoplasm, left ventricular wall thrombus, congestive heart failure, bacterial endocarditis, cardiomyopathy, myocardial infarction within previous 30 days; ii. Multiple cerebral infarctions in more than one vascular territory (e.g., bilateral MCA, or an MCA and a basilar artery) confirmed MRI diffusion-weighted imaging;

Suspected or confirmed uncommon causes of cerebrovascular disorders: arterial dissection, Moyamoya disease, vasculitis disease, neurosyphilis, radiation induced vasculopathy, fibromuscular dysplasia, benign angiopathy of central nervous system, post-partum angiopathy, suspected vasospastic process, suspected recanalized embolus etc.;

Subclavian artery stenosis ≥ 50% or subclavian steal syndrome;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Remote Ischemic Conditioning (RIC) treatment

    Device

    RIC will be given twice a day for 10-14 days. RIC will be applied using an automated RIC device. The cuff of the RIC medical device will be placed around the bilateral upper limbs. Five cycles of cuff inflation (200mmHg for 5 minutes) and deflation (for 5 minutes) for a total procedure time of 50 minutes.

  • Medical Management

    Drug

    Patients will receive standard guideline-directed medical therapy, which will include monitor vital signs, management of blood pressure, glucose and lipids, antithrombotic therapy if appropriate.

Treatment groups

1,150 Participants
are divided into 2 treatment groups
Group A: Remote Ischemic Conditioning + Medical ManagementExperimental treatment 2 interventions
Group B: Medical ManagementActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Modified Rankin Scale (mRS) 0-1 at 90 days

The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of patients who have suffered from a stroke or other causes of neurological disability. The scale runs from 0-6 with "0" being perfect health without symptoms to "6" being death. Score 0: No symptoms. Score 1: No significant disability. Able to carry out all usual activities, despite some symptoms. Score 2: Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. Score 3: Moderate disability. Requires some help, but able to walk unassisted. Score 4: Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. Score 5: Severe disability. Requires constant nursing care and attention, bedridden, incontinent. Score 6: Dead.

Time frame
at 90 days after randomization

Secondary outcomes

1

Modified Rankin Scale (mRS) 0-2 at 90 days

Time frame
at 90 days after randomization
2

Distribution of the Modified Rankin Scale (mRS) at 90 days

Time frame
at 90 days after randomization
3

Early neurological deterioration within 48 hours

Time frame
within 48 hours after randomization
4

Change of NIHSS scores from baseline to 12 days

Time frame
at 12 days after randomization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.